CFDE Workbench
Information PortalData PortalKnowledge Portal
Search
Graph
Enrichment
Cross
Assistant
Data Matrix
Use Cases
Tools & Workflows
Submit
Documentation
CFDE Workbench

Premenstrual Dysphoric Disorder (Disease Or Phenotype)

Nci:C197949
Msh:D065446
Medcin:MEDCIN:32779
Mdr:MDR:10051537
Id:8ea2de85-a522-5996-b222-b396f1e32348
Icd10cm:F32.81
Chv:CHV:37769
Results found

Linked to

 

Label

Description

 

Knowledge Graph Assertion

Fluoxetine indication Premenstrual Dysphoric Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Levomefolic acid indication Premenstrual Dysphoric Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US8987239, A::US9034856, A indication Premenstrual Dysphoric Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Paroxetine indication Premenstrual Dysphoric Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Sertraline indication Premenstrual Dysphoric Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

17-alpha-Ethynyl estradiol indication Premenstrual Dysphoric Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

17-beta-estradiol indication Premenstrual Dysphoric Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Fluoxetine indication Premenstrual Dysphoric Disorder

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Levomefolic acid indication Premenstrual Dysphoric Disorder

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    US8987239, A::US9034856, A indication Premenstrual Dysphoric Disorder

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Paroxetine indication Premenstrual Dysphoric Disorder

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Sertraline indication Premenstrual Dysphoric Disorder

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    17-alpha-Ethynyl estradiol indication Premenstrual Dysphoric Disorder

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    17-beta-estradiol indication Premenstrual Dysphoric Disorder

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2025
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2025
    This repository is under review for potential modification in compliance with Administration directives.